Oligonucleotide Therapeutics Society

The Oligonucleotide Therapeutics Society is a 501(c)6 nonprofit organization incorporated in the United States in 2004. Based in San Diego, California, the Society is a dedicated forum for researchers and developers in the field of oligonucleotide therapeutics. With a small team of four employees, OTS focuses on fostering collaboration between academia and industry to advance the development and application of oligonucleotide therapies. The Oligonucleotide Therapeutics Society aims to bring together experts from diverse disciplines within oligonucleotide research, including chemistry, delivery, biology, immunology, and clinical medicine. The Society's annual meeting, a highly regarded event in the field, provides a platform for cross-disciplinary exchange and the generation of groundbreaking new ideas. OTS distinguishes itself through its commitment to open collaboration and its role in shaping the future of oligonucleotide therapeutics. The Society's annual meeting serves as a catalyst for innovation and progress in the field, bringing together leading experts to share knowledge and advance the potential of oligonucleotide drugs to transform therapeutic modalities. For further information, please visit the Oligonucleotide Therapeutics Society website at oligotherapeutics.org.